X Li, S Guo, XK Xiong, BY Peng, JM Huang… - Journal of …, 2019 - ncbi.nlm.nih.gov
While cisplatin is a first-line chemotherapeutic drug commonly used to treat patients with oral
squamous cell carcinoma (OSCC), the cisplatin-resistance poses a major challenge for its …